Cancer death
In the ASPREE trial, cancer was the main contributor to the excess mortality seen with aspirin (1.6 excess deaths per 1,000 person-years). The authors point out that this is a signal rather than an established causal relationship.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.